›› 2019, Vol. 10 ›› Issue (3): 158-161.
Previous Articles Next Articles
Xiao-Han ZHU1,
Received:
2019-04-22
Revised:
2019-07-09
Online:
2019-09-25
Published:
2019-09-25
Xiao-Han ZHU. Research progress on the role of Small leucine-rich proteoglycans in bone tissue physiological and pathological process and the regulation[J]. , 2019, 10(3): 158-161.
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
[1] | Schaefer L, Schaefer RM.Proteoglycans: from structural compounds to signaling molecules[J].Cell Tissue Res, 2010, 339(1):237-246 |
[2] | McEwan PA, Scott PG, Bishop PN, et al.Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans[J].J Struct Biol, 2006, 155(2):294-305 |
[3] | Schaefer L, Iozzo RV.Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction[J].J Biol Chem, 2008, 283(31):21305-21309 |
[4] | Iozzo RV.The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth[J].Crit Rev Biochem Mol Biol, 1997, 32(2):141-174 |
[5] | Bianco P, Fisher LW, Young MF, et al.Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues[J].J Histochem Cytochem, 1990, 38(11):1549-1563 |
[6] | Xu T, Bianco P, Fisher LW, et al.Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice[J].Nat Genet, 1998, 20(1):78-82 |
[7] | Chen XD, Shi S, Xu T, et al.Age-related osteoporosis in biglycan-deficient mice is related to defects in bone marrow stromal cells[J].J Bone Miner Res, 2002, 17(2):331-340 |
[8] | Berendsen AD, Pinnow EL, Maeda A, et al.Biglycan modulates angiogenesis and bone formation during fracture healing[J].Matrix Biol, 2014, 35:223-231 |
[9] | Myren M, Kirby DJ, Noonan ML, et al.Biglycan potentially regulates angiogenesis during fracture repair by altering expression and function of endostatin[J].Matrix Biol, 2016, 52/54:141-150 |
[10] | Sommarin Y, Wendel M, Shen Z, et al.Osteoadherin, a cell-binding keratan sulfate proteoglycan in bone, belongs to the family of leucine-rich repeat proteins of the extracellular matrix[J].J Biol Chem, 1998, 273(27):16723-16729 |
[11] | Sugars RV, Olsson ML, Marchner S, et al.The glycosylation profile of osteoadherin alters during endochondral bone formation[J].Bone, 2013, 53(2):459-467 |
[12] | Tashima T, Nagatoishi S, Caaveiro JMM, et al.Molecular basis for governing the morphology of type-I collagen fibrils by Osteomodulin[J].Commun Biol, 2018, 1(1):33- |
[13] | Tashima T, Nagatoishi S, Sagara H, et al.Osteomodulin regulates diameter and alters shape of collagen fibrils[J].Biochem Biophys Res Commun, 2015, 463(3):292-296 |
[14] | Han XG, Wang DK, Gao F, et al.Bone morphogenetic protein 2 and decorin expression in old fracture fragments and surrounding tissues[J].Genet Mol Res, 2015, 14(3):11063-11072 |
[15] | Ueda M, Goto T, Kuroishi KN, et al.Asporin in compressed periodontal ligament cells inhibits bone formation[J].Arch Oral Biol, 2016, 62:86-92 |
[16] | Yano K, Washio K, Tsumanuma Y, et al.The role of Tsukushi (TSK), a small leucine-rich repeat proteoglycan, in bone growth[J].Regen Ther, 2017, 7:98-107 |
[17] | Geerkens C, Vetter U, Just W, et al.The X-chromosomal human biglycan gene BGN is subject to X inactivation but is transcribed like an X-Y homologous gene[J].Hum Genet, 1995, 96(1):44-52 |
[18] | Nielsen KL, Allen MR, Bloomfield SA, et al.Biglycan deficiency interferes with ovariectomy-induced bone loss[J].J Bone Miner Res, 2003, 18(12):2152-2158 |
[19] | Juchtmans N, Dhollander AA, Coudenys J, et al.Distinct dysregulation of the small leucine-rich repeat protein family in osteoarthritic acetabular labrum compared to articular cartilage[J].Arthritis Rheumatol, 2015, 67(2):435-441 |
[20] | Edsberg LE, Crowgey EL, Osborn PM, et al.A survey of proteomic biomarkers for heterotopic ossification in blood serum[J].J Orthop Surg Res, 2017, 12(1):69- |
[21] | Lyon SM, Mayampurath A, Song D, et al.Whole-Proteome Analysis of Human Craniosynostotic Tissue Suggests a Link between Inflammatory Signaling and Osteoclast Activation in Human Cranial Suture Patency[J].Plast Reconstr Surg, 2018, 141(2):250e-260e |
[22] | Sanchez C, Mazzucchelli G, Lambert C, et al.Comparison of secretome from osteoblasts derived from sclerotic versus non-sclerotic subchondral bone in OA: A pilot study[J].PLoS ONE, 2018, 13(3):e0194591- |
[23] | Benayahu D, Shur I, Marom R, et al.Cellular and molecular properties associated with osteosarcoma cells[J].J Cell Biochem, 2001, 84(1):108-114 |
[24] | Datsis GA, Berdiaki A, Nikitovic D, et al.Parathyroid hormone affects the fibroblast growth factor-proteoglycan signaling axis to regulate osteosarcoma cell migration[J].FEBS J, 2011, 278(19):3782-3792 |
[25] | Gómez-Herrera Z, Molina-Frechero N, Damian-Matsumura P, et al.Expression of proteoglycans in two types of ameloblastoma: novel Immunohistochemical findings[J].J Biol Regul Homeost Agents, 2018, 32(3):479-487 |
[26] | Lieveld M, Bodson E, De Boeck G, et al.Gene expression profiling of giant cell tumor of bone reveals downregulation of extracellular matrix components decorin and lumican associated with lung metastasis[J].Virchows Arch, 2014, 465(6):703-713 |
[27] | Nemani N, Santo L, Eda H, et al.Role of decorin in multiple myeloma (MM) bone marrow microenvironment[J].J Bone Miner Res, 2015, 30(3):465-470 |
[28] | Yang Y, Xu W, Neill T, et al.Systemic Delivery of an Oncolytic Adenovirus Expressing Decorin for the Treatment of Breast Cancer Bone Metastases[J].Hum Gene Ther, 2015, 26(12):813-825 |
[29] | Xu W, Neill T, Yang Y, et al.The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer[J].Gene Ther, 2015, 22(3):247-256 |
[30] | Chen XD, Fisher LW, Robey PG, et al.The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation[J].FASEB J, 2004, 18(9):948-958 |
[31] | Mochida Y, Parisuthiman D, Yamauchi M.Biglycan is a positive modulator of BMP-2 induced osteoblast differentiation[J].Adv Exp Med Biol, 2006, 585:101-113 |
[32] | Bi Y, Stuelten CH, Kilts T, et al.Extracellular matrix proteoglycans control the fate of bone marrow stromal cells[J].J Biol Chem, 2005, 280(34):30481-30489 |
[33] | Wang X, Harimoto K, Xie S, et al.Matrix protein biglycan induces osteoblast differentiation through extracellular signal-regulated kinase and Smad pathways[J].Biol Pharm Bull, 2010, 33(11):1891-1897 |
[34] | Berendsen AD, Fisher LW, Kilts TM, et al.Modulation of canonical Wnt signaling by the extracellular matrix component biglycan[J].Proc Natl Acad Sci U S A, 2011, 108(41):17022-17027 |
[35] | Rehn AP, Chalk AM, Wendel M.Differential regulation of osteoadherin (OSAD) by TGF-beta1 and BMP-2[J].Biochem Biophys Res Commun, 2006, 349(3):1057-1064 |
[36] | Wang L, Foster BL, Kram V, et al.Fibromodulin and Biglycan Modulate Periodontium through TGFbetaBMP Signaling[J].J Dent Res, 2014, 93(8):780-787 |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||